ClinicalTrials.gg

Adverum Biotechnologies, Inc. clinical trials

Acquired by Eli Lilly and Company, Dec 9, 2025 · source ↗

The registry lists 11 studies whose lead sponsor is Adverum Biotechnologies, Inc. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2026.

Before and after it joined Eli Lilly and Company

First submitted before Adverum Biotechnologies, Inc. became part of Eli Lilly and Company
9
First submitted after Adverum Biotechnologies, Inc. became part of Eli Lilly and Company
2
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Coming up

2 of Adverum Biotechnologies, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. 1N

Add all 2 to your calendar (.ics) → With an account.

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now218%
  • Under way, not recruiting436%
  • Completed545%

Phase

  • Phase 24
  • Phase 32
  • Phase 12

Where

  • United States10
  • France2
  • Puerto Rico2
  • United Kingdom1

Over the years

  1. 16
  2. 17
  3. 218
  4. 19
  5. 20
  6. 21
  7. 22
  8. 23
  9. 24
  10. 25
  11. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Adverum Biotechnologies, Inc.11 studies

Something wrong with this grouping? Tell us on the Eli Lilly and Company page.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. All Eli Lilly and Company studies →